| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 21, 2024 | Jun 25, 2024 | Ernexa Therapeutics Inc. | Sr. VP of Finance | Sell | 27.5 | -180 | -13.19% | ✗ | $349.2 |
| Jun 21, 2023 | Jun 23, 2023 | Ernexa Therapeutics Inc. | President | Sell | 27.5 | -179 | -16.17% | ✗ | $443.9 |
| Jun 21, 2022 | Jun 23, 2022 | Ernexa Therapeutics Inc. | President | Sell | 27.5 | -3,586 | -21.15% | ✗ | $1.7K |
| Mar 24, 2021 | Mar 26, 2021 | Ernexa Therapeutics Inc. | Former SVP of Finance | Sell | 46.3 | -6,094 | -21.99% | ✗ | $16.3K |
| Mar 19, 2021 | Mar 22, 2021 | Ernexa Therapeutics Inc. | SVP of Finance | Sell | 52.5 | -116 | -0.42% | ✗ | $409.5 |
| Feb 19, 2021 | Feb 22, 2021 | Ernexa Therapeutics Inc. | SVP of Finance | Sell | 52.5 | -115 | -0.41% | ✗ | $553.2 |
| Jan 19, 2021 | Jan 20, 2021 | Ernexa Therapeutics Inc. | SVP of Finance | Sell | 47.5 | -1,400 | -4.77% | ✗ | $3.6K |
| Dec 19, 2020 | Dec 21, 2020 | Ernexa Therapeutics Inc. | SVP of Finance | Sell | 52.5 | -100 | -0.34% | ✗ | $217 |
| Nov 20, 2020 | Nov 20, 2020 | Ernexa Therapeutics Inc. | SVP of Finance | Sell | 52.5 | -98 | -0.33% | ✗ | $184.2 |
| Oct 21, 2020 | Oct 21, 2020 | Ernexa Therapeutics Inc. | SVP of Finance | Sell | 47.5 | -1,178 | -3.83% | ✗ | $2.4K |
| Sep 22, 2020 | Sep 23, 2020 | Ernexa Therapeutics Inc. | SVP of Finance | Sell | 52.5 | -97 | -0.31% | ✗ | $193 |
| Aug 25, 2020 | Aug 26, 2020 | Ernexa Therapeutics Inc. | SVP of Finance | Sell | 52.5 | -98 | -0.32% | ✗ | $256.8 |
| Jul 28, 2020 | Jul 28, 2020 | Ernexa Therapeutics Inc. | SVP of Finance | Sell | 47.5 | -1,178 | -3.67% | ✗ | $2.2K |
| Jun 29, 2020 | Jun 30, 2020 | Ernexa Therapeutics Inc. | SVP of Finance | Sell | 52.5 | -97 | -0.30% | ✗ | $305.6 |
| May 20, 2020 | May 20, 2020 | Ernexa Therapeutics Inc. | SVP of Finance | Sell | 52.5 | -115 | -0.36% | ✗ | $178.3 |
| Apr 21, 2020 | Apr 22, 2020 | Ernexa Therapeutics Inc. | SVP of Finance | Sell | 47.5 | -1,392 | -4.13% | ✗ | $1.7K |
| Mar 25, 2020 | Mar 25, 2020 | Ernexa Therapeutics Inc. | SVP of Finance | Sell | 52.5 | -114 | -0.34% | ✗ | $168.7 |
| Feb 25, 2020 | Feb 26, 2020 | Ernexa Therapeutics Inc. | SVP of Finance | Sell | 52.5 | -115 | -0.34% | ✗ | $235.8 |
| Jan 19, 2020 | Jan 31, 2020 | Ernexa Therapeutics Inc. | SVP of Finance | Sell | 90.0 | +24,886 | 275.35% | ✗ | $277 |
| Dec 19, 2019 | Dec 20, 2019 | Ernexa Therapeutics Inc. | SVP of Finance | Sell | 47.5 | -94 | -1.03% | ✗ | $256.6 |
| Nov 20, 2019 | Nov 20, 2019 | Ernexa Therapeutics Inc. | SVP of Finance | Sell | 47.5 | -95 | -1.03% | ✗ | $248.9 |
| Oct 23, 2019 | Oct 23, 2019 | Ernexa Therapeutics Inc. | SVP of Finance | Sell | 47.5 | -94 | -1.00% | ✗ | $270.7 |
| Sep 24, 2019 | Sep 24, 2019 | Ernexa Therapeutics Inc. | SVP of Finance | Sell | 47.5 | -454 | -4.64% | ✗ | $1K |
| Aug 27, 2019 | Aug 27, 2019 | Ernexa Therapeutics Inc. | VP of Finance | Sell | 52.5 | -35 | -0.36% | ✗ | $97 |
| Jul 30, 2019 | Jul 30, 2019 | Ernexa Therapeutics Inc. | VP of Finance | Sell | 52.5 | -34 | -0.35% | ✗ | $108.1 |
| Jun 21, 2019 | Jun 24, 2019 | Ernexa Therapeutics Inc. | VP of Finance | Sell | 52.5 | -34 | -0.34% | ✗ | $118 |
| May 21, 2019 | May 21, 2019 | Ernexa Therapeutics Inc. | VP of Finance | Sell | 52.5 | -35 | -0.35% | ✗ | $101.2 |
| Apr 23, 2019 | Apr 25, 2019 | Ernexa Therapeutics Inc. | VP of Finance | Sell | 52.5 | -34 | -0.34% | ✗ | $129.2 |
| Mar 26, 2019 | Mar 27, 2019 | Ernexa Therapeutics Inc. | VP of Finance | Sell | 52.5 | -34 | -0.34% | ✗ | $126.5 |
| Feb 26, 2019 | Feb 26, 2019 | Ernexa Therapeutics Inc. | VP of Finance | Sell | 47.5 | -35 | -1.16% | ✗ | $119.7 |
| Jan 29, 2019 | Jan 29, 2019 | Ernexa Therapeutics Inc. | VP of Finance | Sell | 47.5 | -34 | -1.11% | ✗ | $108.1 |
| Dec 19, 2018 | Dec 20, 2018 | Ernexa Therapeutics Inc. | VP of Finance | Sell | 50.0 | -28 | -0.91% | ✗ | $56 |
| Nov 20, 2018 | Nov 20, 2018 | Ernexa Therapeutics Inc. | VP of Finance | Sell | 50.0 | -29 | -0.93% | ✗ | $83.2 |
| Oct 23, 2018 | Oct 24, 2018 | Ernexa Therapeutics Inc. | VP of Finance | Sell | 50.0 | -28 | -0.89% | ✗ | $121 |
| Sep 25, 2018 | Sep 25, 2018 | Ernexa Therapeutics Inc. | VP of Finance | Sell | 47.5 | -169 | -5.12% | ✗ | $714.9 |